Factors associated with time to availability for cases reported to population-based cancer registries⋆
- 46 Downloads
Objective: Population-based cancer registries provide an excellent source of data for cancer surveillance and research. However, delays in reporting and processing can affect the accuracy of incidence rates and the availability of cases for research. This study was designed to describe factors related to delays in availability of cancer cases for epidemiologic analysis.
Methods: We identified all cancer cases diagnosed in 2000 and reported to the California Cancer Registry by August 2004. We analyzed factors associated with time to availability, defined as the time from diagnosis until the time the case was available for research.
Results: A total of 137,270 cancer cases were reported during the study period. The median time to availability for all cases was 382 days. Forty-five percent of cases were available within the first 12 months and 96% were available within 24 months after diagnosis. Cases reported by hospitals had the shortest time to availability (373 days) followed by doctors’ offices and laboratories. Melanoma and prostate cancers had longer times to be available than other types of cancer. Time to availability varied by geographic region, but differences by age, gender, race and stage at diagnosis were minimal or non-significant.
Conclusion: Strategies are needed to improve timeliness without sacrificing quality and completeness.
Keywordsneoplasms population surveillance registries.
Unable to display preview. Download preview PDF.
- 3.Morris, C, Cohen, R, Perkins, C, et al. 2000Cancer in California: 1988–1997California Department of Health Services, Cancer Surveillance Section; June, 2000Sacramento, CAGoogle Scholar
- 4.California Department of Health Services1995Cancer Reporting in California: Abstracting and Coding Procedures for Hospitals. California Cancer Reporting System Standards3California Cancer Registry, Data Standards and Assessment Unit; August 1995Sacramento, CAVol. 1Google Scholar
- 5.Percy, C, Van Holten, V, Muir, C 1990International Classification of Diseases for Oncology2World Health OrganizationEnglandGoogle Scholar
- 6.Shambaugh E, Ries L, Young J,et al. (1992) SEER Extent of Disease — 1988 Codes and Coding Instructions. 2nd edn.Google Scholar
- 7.Seiffert J (1993) SEER Program: Comparative Staging Guide for Cancer, version 1.1: National Cancer Institute; June, 1993. Report No.: NIH Publication No. 93–3640.Google Scholar
- 8.Collett, D 1999Modelling Survival Data in Medical ResearchChapman & Hall/CRCNew YorkGoogle Scholar